U.S. federal trademark · Serial No. 79368733
Cancer treatment targeting sortilin receptors (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations)
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.